{"id":54619,"date":"2023-03-08T12:04:19","date_gmt":"2023-03-08T11:04:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/in-situ-hybridization-global-market-report-2022-technological-advancements-in-the-field-of-in-vitro-diagnostics-drive-growth-researchandmarkets-com\/"},"modified":"2023-03-08T12:04:19","modified_gmt":"2023-03-08T11:04:19","slug":"in-situ-hybridization-global-market-report-2022-technological-advancements-in-the-field-of-in-vitro-diagnostics-drive-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/in-situ-hybridization-global-market-report-2022-technological-advancements-in-the-field-of-in-vitro-diagnostics-drive-growth-researchandmarkets-com\/","title":{"rendered":"In Situ Hybridization Global Market Report 2022: Technological Advancements in the Field of In Vitro Diagnostics Drive Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology, By Probe, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2023 – 2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global in situ hybridization market size is expected to reach USD 2.42 billion by 2030 and is set to expand at 6.9% CAGR from 2023 – 2030. Situ Hybridization (ISH) is extensively utilized for research and clinical applications of diagnostics. ISH is a popular approach among researchers as it aids in determining the relationship between the distribution of specific nucleic acids and the target gene protein products. Hence, expanding the scope of ISH in applications is accelerating and leading to further research.\n<\/p>\n

\nThe increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.\n<\/p>\n

\nFurthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.\n<\/p>\n

\nOwing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.\n<\/p>\n

\nCOVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.\n<\/p>\n

\nThe growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.\n<\/p>\n

\nOn the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.\n<\/p>\n

\nMarket Dynamics<\/strong>\n<\/p>\n

\nMarket Drivers\n<\/p>\n